SEARCH

SEARCH BY CITATION

References

  • 1
    Starzl TE, discussion of Murray JE, Wilson RE, Tilney NL, Merrill JP, Cooper WC, Birtch AG, et al. Five years experience in renal transplantation with immunosuppressive drugs: Survival, function, complications, and the role of lymphocyte depletion by thoracic duct fistula. Ann Surg 1968; 168:416435. MEDLINE
  • 2
    Penn I, Hammond W, Brettschneider L, Starzl TE. Malignant lymphomas in transplantation patients. Transplant Proc 1969; 1:106112. MEDLINE
  • 3
    Penn I, Starzl TE. Malignant tumors arising de novo in immunosuppressed organ transplant recipients. Transplantation 1972; 14:407417. MEDLINE
  • 4
    Farge D: Kaposi's sarcoma in organ transplant recipients. The Collaborative Transplant Research Group of the Ile de France. Eur J Med 1993; 2:339343. MEDLINE
  • 5
    Penn I. Occurrence of cancers in immunosuppressed organ transplant recipients. In: TerasakiP, CeckaM (eds). Clinical transplantation 1990. Los Angeles: UCLA Tissue Typing, 1990:5362.
  • 6
    Sheil AGR. Cancer in dialysis and transplant patients. In: MorrisPJ (ed). Kidney transplantation: Principles and practice. Philadelphia: Saunders, 1994:390400.
  • 7
    McKhann CF. Primary malignancy in patients undergoing immunosuppression for renal transplantation. Transplantation 1969; 8:209212. MEDLINE
  • 8
    Jain AB, Yee LD, Nalesnik MA, Youk A, Marsh G, Reyes J, et al. Comparative incidence of de novo nonlymphoid malignancies after liver transplantation under tacrolimus using Surveillance Epidemiologic End Result data. Transplantation 1998; 66:11931200. MEDLINE
  • 9
    Curtil A, Robin J, Tronc F, Ninet J, Bolssonnat P, Champsaur G. Malignant neoplasms following cardiac transplantation. Eur J Cardiothorac Surg 1997; 12:101106. MEDLINE
  • 10
    Kehinde EO, Petermann A, Morgan JD, Donnelly PK, Veitch PS, Bell PRF. Triple therapy and incidence of de novo cancer in renal transplant recipients. Br J Surg 1994; 81:985986. MEDLINE
  • 11
    Penn I. Incidence and treatment of neoplasia after transplantation. J Heart Lung Transplant 1993; 12(suppl):S328S336. MEDLINE
  • 12
    Penn I. Posttransplantation de novo tumors in liver allograft recipients. Liver Transpl Surg 1996; 2:5259. MEDLINE
  • 13
    Sheil AGR. Malignancy following liver transplantation: A report from the Australian Combined Liver Transplant Registry. Transplant Proc 1995; 27:1247. MEDLINE
  • 14
    Sheil AGR. Malignancy uniquely impacts liver transplantation outcomes [abstract 146]. Seventh Congress of the International Liver Transplantation Society, Berlin, Germany, July 12, 2001.
  • 15
    Kelly DM, Emre S, Guy SR, Miller CM, Schwartz ME, Sheiner PA. Liver transplant recipients are not at increased risk for nonlymphoid solid organ tumors. Cancer 1998; 83:12371243. MEDLINE
  • 16
    Sheiner PA, Magliocca JF, Bodian CA, Kim-Schluger L, Altaca G, Guarrera JV, et al. Long-term medical complications in patients surviving ≥ 5 years after liver transplantation. Transplantation 2000; 69:781789. MEDLINE
  • 17
    Berenguer M, Prieto M, Bustamante M, Carrasco D, Lopez-Andugar R, Mir J, Berenguer J: Incidence of de novo neoplasms after liver transplantation. Med Clin (Barc) 1998; 111:481484. MEDLINE
  • 18
    Haagsma EB, Hagens VE, Schaapveld M, van den Berg AP, de Vries EG, Klompmaker IJ, et al. Increased cancer risk after liver transplantation: A population-based study. J Hepatol 2001; 34:8491. MEDLINE
  • 19
    Levy M, Backman L, Husberg B, Goldstein R, McMillan R, Gibbs J, et al. De novo malignancy following liver transplantation: A single center study. Transplant Proc 1993; 25:13971399. MEDLINE
  • 20
    Sven J, Steinmüller T, Neuhaus R, Rayes N, Klupp J, Guckelberger O, et al. De novo tumors after liver transplantation [abstract 154]. Seventh Congress of the International Liver Transplantation Society, Berlin, Germany, July 12, 2001.
  • 21
    Jain A, DiMartini A, Kashyap R, Youk A, Rohal S, Fung J. Long-term follow-up after liver transplantation for alcoholic liver disease under tacrolimus. Transplantation 2000; 70:13351342. MEDLINE
  • 22
    RiesLAG, KosaryCL, HankeyBF, HarrasA, MillerBA, EdwardsBK (eds). SEER cancer statistics review, 1973–1993: Tables and graphs. Bethesda, MD: National Cancer Institute, 1996.
  • 23
    Jain A, Mazariegos G, Kashyap R, Green M, Gronsky C, Starzl TE, et al. Comparative long-term evaluation of tacrolimus and cyclosporine in pediatric liver transplantation. Transplantation 2000; 70:617625. MEDLINE
  • 24
    Cacciarelli TV, Green M, Jaffe R, Mazariegos GV, Jain A, Fung JJ, Reyes J. Management of posttransplant lymphoproliferative disease in pediatric liver transplant recipients receiving primary tacrolimus (FK506) therapy. Transplantation 1998; 66:10471052. MEDLINE
  • 25
    Newell KA, Alonso EM, Whitington PF, Bruce DS, Millis JM, Piper JB, et al. Posttransplant lymphoproliferative disease in pediatric liver transplantation. Interplay between primary Epstein-Barr virus infection and immunosuppression. Transplantation 1996; 62:370375. MEDLINE
  • 26
    Glez-Chamorro A, Jimenez C, Moreno-Gonzolez E, Glez-Pinto I, Loinaz C, Gomez R, et al. Management and outcome of liver recipients with post-transplant lymphoproliferative disease. Hepatogastroenterology 2000; 47:211219. MEDLINE
  • 27
    Dent PB, Peterson RDA, Good RA. The relationship between immunologic function and oncogenesis: Immunologic deficiency disease. In: GoodRA, BergsmaD (eds). Man. Birth defects original article series, vol 4. New York: National Foundation Press, 1967:443.
  • 28
    Sheil AG. Cancer in organ transplant recipients: Part of an induced immune deficiency syndrome. BMJ 1984; 288:659661. MEDLINE
  • 29
    Kinlen LJ. Incidence of cancer in rheumatoid arthritis and other disorders after immunosuppressive treatment. Am J Med 1985; 78(suppl):S44S49.
  • 30
    Taylor AEM, Shuster S. Skin cancer after renal transplantation: The causal role of azathioprine. Acta Derm Venereol (Stockh) 1992; 72:115119. MEDLINE
  • 31
    Hojo M, Morimoto T, Maluccio M, Asano T, Morimoto K, Lagman M, et al. Cyclosporine induces cancer progression by a cell-autonomous mechanism. Nature 1999; 397:530534. MEDLINE
  • 32
    Dalton A, Curtis D, Harrington CI. Synergistic effects of azathioprine and ultraviolet light detected by sister chromatid exchange analysis. Cancer Genet Cytogenet 1990; 45:9399. MEDLINE
  • 33
    DeJong M, Coppee MD, DeHalleux F, Deckers C, Maisin H. Immunosuppression and carcinogenesis: Effects of azathioprine on induction of sarcomas by 3-methylcholanthrene. Neoplasma 1977; 24:139146. MEDLINE
  • 34
    Lennard L, Thomas S, Harrington CI, Maddocks JL. Skin cancer in renal transplant recipients is associated with increased concentrations of 6-thioguanine nucleotide in red blood cells. Br J Dematol 1985; 113:723729.
  • 35
    Schoeffner DJ, Thorgeirsson UP. Susceptibility of nonhuman primates to carcinogens of human relevance. In Vivo 2000; 14:149156. MEDLINE
  • 36
    Mooradian DL, McCarthy JB, Komanduri KV, Furcht LT. Effects of transforming growth factor-beta 1 on human pulmonary adenocarcinoma cell adhesion, motility, and invasion in vitro. J Natl Cancer Inst 1992; 84:523537. MEDLINE
  • 37
    Shin GT, Khanna A, Ding R, Sharma VK, Lagman M, Li B, Suthanthiran M. In vivo expression of transforming growth factor-beta 1 in humans: Stimulation by cyclosporine. Transplantation 1998; 65:313318. MEDLINE
  • 38
    Khanna A, Cairns V, Hosenpud JD. Tacrolimus induces increased expression of transforming growth factor-beta 1 in mammalian lymphoid as well as nonlymphoid cells. Transplantation 1999; 67:614619. MEDLINE
  • 39
    Mohammed MA, Robertson H, Booth TA, Balupuri S, Kirby JA, Talbot D. TGF-beta expression in renal transplant biopsies: A comparative study between cyclosporin-A and tacrolimus. Transplantation 2000; 69:10021005. MEDLINE
  • 40
    Flattery M. Incidence and treatment of cancer in transplant recipients. J Transpl Coord 1998; 8:105110. MEDLINE
  • 41
    Paya CV, Fung JJ, Nalesnik MA, Kieff E, Green M, Gores G, et al. Epstein-Barr virus-induced posttransplant lymphoproliferative disorders. Transplantation 1999; 68:15171525. MEDLINE
  • 42
    Devarbhavi H, Wiesner RH, Habermann TM, Krom RAF. Late onset post-transplant lymphoproliferative disorders (PTLD) after liver transplantation (LT) is often unrelated to Epstein-Barr virus infection (EBV) [abstract 156]. Seventh Congress of the International Liver Transplantation Society, Berlin, Germany, July 12, 2001.
  • 43
    Nalesnik MA, Jaffe R, Starzl TE, Demetris AJ, Porter K, Burnham JA, et al. The pathology of posttransplant lymphoproliferative disorders occurring in the setting of cyclosporine A-prednisone immunosuppression. Am J Pathol 1988; 133:173192. MEDLINE
  • 44
    Malatack JF, Gartner JC Jr, Urbach AH, Zitelli BH. Orthotopic liver transplantation, Epstein-Barr virus, cyclosporine, and lymphoproliferative disease: A growing concern. J Pediatr 1991; 118:667675. MEDLINE
  • 45
    Hezode C, Duvoux C, Germanidis G, Roudot-Thoraval F, Vincens AL, Gaulard P, et al. Role of hepatitis C virus in lymphoproliferative disorders after liver transplantation. Hepatology 1999; 30:775778. MEDLINE
  • 46
    Buda A, Caforio A, Calabrese F, Fagiuoli S, Pevere S, Livi U, et al. Lymphoproliferative disorders in heart transplant recipients: Role of hepatitis C virus (HCV) and Epstein-Barr virus (EBV) infection. Transpl Int 2000; 13(suppl):S402S405. MEDLINE
  • 47
    Starzl TE, Nalesnik MA, Porter KA, Iwatsuki S, Rosenthal JT, Shaw BW, et al. Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporine-steroid therapy. Lancet 1984; 1:583587. MEDLINE
  • 48
    Benkerrous M, Jais JP, Leblond V, Durandy A, Sutton L, Bordigoni P, et al. Anti-B-cell monoclonal antibody treatment of severe posttransplant B-lymphoproliferative disorder: Prognostic factors and long-term outcome. Blood 1998; 92:31373147. MEDLINE
  • 49
    Zompi S, Tulliez M, Conti F, Leblond V, Gaulard P, Blanche P, et al. Rituximab (anti-CD20 monoclonal antibody) for the treatment of patients with clonal lymphoproliferative disorders after orthotopic liver transplantation: A report of three cases. J Hepatol 2000; 32:521527. MEDLINE
  • 50
    McCarthy M, Ramage J, McNair A, Gane E, Portmann B, Pagliuca A, et al. The clinical diversity and role of chemotherapy in lymphoproliferative disorder in liver transplant recipients. J Hepatol 1997; 27:10151021. MEDLINE
  • 51
    Matsushima Y. Chromosomal aberrations in the lymphocytes of alcoholics and former alcoholics. Neuropsychobiology 1987; 17:2429. MEDLINE
  • 52
    Huttner E, Matthies U, Nikolova T, Ehrenreich H. A follow-up study on chromosomal aberrations in lymphocytes of alcoholics during early, medium, and long-term abstinence. Alcohol Clin Exp Res 1999; 23:344348. MEDLINE
  • 53
    Singhal PC, Reddy K, Ding G, Kapasi A, Franki N, Ranjan R, et al. Ethanol-induced macrophage apoptosis: The role of TGF-beta. J Immunol 1999; 162:30313036. MEDLINE
  • 54
    Kamimura S, Tsukamoto H. Cytokine gene expression by Kuppfer cells in experimental alcoholic liver disease. Hepatology 1995; 22:13041309. MEDLINE
  • 55
    Hunt JD, Robert EG, Zieske AW, Bautista AP, Bukara M, Lei D, et al. Orthotopic human lung carcinoma xenografts in BALB/c mice immunosuppressed with anti-CD4 monoclonal antibodies and chronic alcohol consumption. Cancer 2000; 88:468479. MEDLINE
  • 56
    Jerrells TR, Saad AJ, Domiati-Saad R. Effects of ethanol on parameters of cellular immunity and host defense mechanisms to infectious agents. Alcohol 1992; 9:459463. MEDLINE
  • 57
    Thun MJ, Peto R, Lopez AD, Monaco JH, Henley SJ, Heath CW, Doll R. Alcohol consumption and mortality among middle-aged and elderly US adults. N Engl J Med 1997; 337:17051714. MEDLINE
  • 58
    Castelli E, Hrelia P, Maffei F, Fimognari C, Foschi FG, Caputo F, et al. Indicators of genetic damage in alcoholics: Reversibility after alcohol abstinence. Hepatogastroenterology 1999; 46:16641668. MEDLINE
  • 59
    Castellsague X, Munoz N, De Stefani E, Victora CG, Quintana MJ, Castelletto R, Rolon PA. Smoking and drinking cessation and risk of esophageal cancer (Spain). Cancer Causes Control 2000; 11:813818. MEDLINE
  • 60
    McGregor JM, Proby CM. The role of papillomaviruses in human non-melanoma skin cancer. Cancer Surv 1996; 26:219236. MEDLINE
  • 61
    Bavinck JNB, Gissmann L, Claas FHJ, Van Der Woude FJ, Persijn GG, Schegget JT, et al. Relation between skin cancer, humoral responses to human papillomaviruses, and HLA class II molecules in renal transplant recipients. J Immunol 1993; 151:15791586. MEDLINE
  • 62
    Penn I. The changing pattern of posttransplant malignancies. Transplant Proc 1991; 23:11011103. MEDLINE
  • 63
    Bismuth H, Samuel D, Venancie PY, Menouar G, Szeleky AM. Development of Kaposi's sarcoma in liver transplant recipients: Characteristics, management, and outcome. Transplant Proc 1991; 23:14381439. MEDLINE
  • 64
    Sheldon J, Henry S, Mourad M, Bodeus M, Squifflet JP, Schulz TF, Goubau P. Human herpes virus 8 infection in kidney transplant patients in Belgium. Nephrol Dial Transplant 2000; 15:14431445. MEDLINE
  • 65
    Marchesa P, Lashner BA, Lavery IC, Milson J, Hull TL, Strong SA, et al. The risk of cancer and dysplasia among ulcerative colitis patients with primary sclerosing cholangitis. Am J Gastroenterol 1997; 92:12851288. MEDLINE
  • 66
    Leidenius MH, Farkkila MA, Karkkainen P, Taskinen EI, Kellokumpu IH, Hockerstedt KA. Colorectal dysplasia and carcinoma in patients with ulcerative colitis and primary sclerosing cholangitis. Scand J Gastroenterol 1997; 32:706711. MEDLINE
  • 67
    Brentnall TA, Haggitt RC, Rabinovitch PS, Kinney MB, Bronner MP, Levine DS, et al. Risk and natural history of colonic neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis. Gastroenterology 1996; 110:331338. MEDLINE
  • 68
    Higashi H, Yanaga K, Marsh JW, Tzakis A, Kakizoe S, Starzl TE. Development of colon cancer after liver transplantation for primary sclerosing cholangitis associated with ulcerative colitis. Hepatology 1990; 11:477480. MEDLINE
  • 69
    Bleday R, Lee E, Jessurun J, Heine J, Wong WD. Increased risk of early colorectal neoplasms after hepatic transplant in patients with inflammatory bowel disease. Dis Colon Rectum 1993; 36:908912. MEDLINE
  • 70
    Fabia R, Levy MF, Testa G, Obiekwe G, Goldstein RM, Husberg BS, et al. Colon carcinoma in patients undergoing liver transplantation. Am J Surg 1998; 176:265269. MEDLINE
  • 71
    Loftus EV Jr, Aguilar HI, Sandborn WJ, Tremaine WJ, Krom RA, Zinsmeister AR, et al. Risk of colorectal neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis following orthotopic liver transplantation. Hepatology 1998; 27:685690. MEDLINE
  • 72
    Hanaway MJ, Trofe J, Buell JF, Lo A, Alloway RR, Beebe T, Woodle ES. Colon cancer risk in liver transplant recipients: The Israel Penn International Transplant Registry (IPITTR) experience [abstract 516]. Transplant 2001: The Joint American Transplant Meeting, May 11–16, 2001, Chicago, IL.
  • 73
    Vera A, Gunson BK, Candinas D, Mayer DA, Buckels JAC, McMaster P, et al. Inflammatory bowel disease and colorectal cancer in patients with primary sclerosing cholangitis following liver transplantation [abstract 517]. Transplant 2001: The Joint American Transplant Meeting, May 11–16, 2001, Chicago, IL.
  • 74
    Bani-Hani K, Sue-Ling H, Johnston D, Axon AT, Martin IG. Barrett's oesophagus: Results from a 13-year surveillance programme. Eur J Gastroenterol Hepatol 2000; 12:649654. MEDLINE
  • 75
    Caygill CP, Reed PI, Johnston BJ, Hill MJ, Ali MH, Levi S. A single centre's 20 years' experience of columnar-lined (Barrett's) oesophagus diagnosis. Eur J Gastroenterol Hepatol 1999; 11:13551358. MEDLINE
  • 76
    Weston AP, Badr AS, Hassanein RS. Prospective multivariate analysis of clinical, endoscopic, and histological factors predictive of the development of Barrett's multifocal high-grade dysplasia or adenocarcinoma. Am J Gastroenterol 1999; 94:34133419. MEDLINE
    Direct Link:
  • 77
    Provenzale D, Schmitt C, Wong JB. Barrett's esophagus: A new look at surveillance based on emerging estimates of cancer risk. Am J Gastroenterol 1999; 94:20432053. MEDLINE
    Direct Link:
  • 78
    Kaiser LR. Immunosuppression in patients with Barrett's esophagus: One piece of the puzzle? Surgery 1992; 112:120. MEDLINE
  • 79
    Ilan Y, Shouval D, Galun E, Goldin E, Ligumsky G, Friedman G, Kaspa RT. Esophageal malignancy after liver transplantation in a patient with Barrett's esophagus. Scand J Gastroenterol 1996; 31:415416. MEDLINE
  • 80
    Trotter JF, Brazer SR: Rapid progression to high-grade dysplasia in Barrett's esophagus after liver transplantation. Liver Transpl 1999; 5:332333.
  • 81
    Dousset B, Boudet MJ, Soubrane O, Calmus Y, Bernard O, Houssin D. Liver transplantation in patients with preexisting malignancy. Transplant Proc 1995; 27:17931795. MEDLINE
  • 82
    Saigal S, Norris S, Srinivasan P, Muiesan P, Rela M, Heaton N, O'Grady J. Successful outcome of orthotopic liver transplantation in patients with preexisting malignant states. Liver Transpl 2001; 7:1115. MEDLINE
  • 83
    Martin DC, Rubini M, Rosen VJ. Cadaveric renal homotransplantation with inadvertent transplantation of carcinoma. JAMA 1965; 192:752754.
  • 84
    Penn I: Transmission of cancer from organ donors. Ann Transplant 1997; 2:712. MEDLINE
  • 85
    Jonas S, Bechstein WO, Lemmens HP, Neuhaus R, Thalman U, Neuhaus P. Liver graft-transmitted glioblastoma multiforme. A case report and experience with 13 multiorgan donors suffering from primary cerebral neoplasia. Transpl Int 1996; 9:426429. MEDLINE
  • 86
    Otley CC, Pittelkow MR. Skin cancer in liver transplant recipients. Liver Transpl 2000; 6:253262. MEDLINE
  • 87
    Barrett WL, First MR, Aron BS, Penn I. Clinical course of malignancies in renal transplant recipients. Cancer 1993; 72:21862189. MEDLINE
  • 88
    Veness MJ, Quinn DI, Ong CS, Keogh AM, Macdonald PS, Cooper SG, Morgan GW. Aggressive cutaneous malignancies following cardiothoracic transplantation. The Australian experience. Cancer 1999; 65:473476.
  • 89
    Stewart T, Tsai SCJ, Grayson H, Henderson R, Opelz G. Incidence of de novo breast cancer in women chronically immunosuppressed after organ transplantation. Lancet 1995; 346:796798. MEDLINE
  • 90
    Fairley CK, Sheil AG, McNeil JJ, Ugoni AM, Disney AP, Giles GG, Amiss N. The risk of ano-genital malignancies in dialysis and transplant recipients. Clin Nephrol 1994; 41:101105. MEDLINE